Evonik holds a research colloquium with the University ofMar 3, 2016

Tokyo at the University of Duisburg-Essen

Kimie Hashiguchi
ManagerRegional Communications

Lectures given by Professors Takuzo Aida and Shigeo Kagami ofthe University of Tokyo
EvonikIndustries

AG(Headquarters:Essen,Germany;hereinafter“Evonik”) and the University of Tokyo (hereinafter “The University ofTokyo”) held a research colloquium at the University of Duisburg-Essen
on February 10. Evonik and The University of Tokyo have been engaged
in the Global Proprius21 strategic partnership agreement since 2014,
and it was this partnership that led to the holding of the researchcolloquium on this occasion.
Prof. Takuzo Aida (Department of Chemistry and Biotechnology, School

TEL +81 (0)3 5323-7319
FAX +81 (0)3 5323-7398
kimie.hashiguchi@evonik.com
Takuya Kobayashi
Manager,Innovation
Networks & Communications
Corporate Innovation
TEL +81 (0)3 5323-7361
FAX +81 (0)3 5323-7398
takuya.kobayashi@evonik.com

of Engineering), Prof. Kohei Tsumoto (Department of Bioengineering,
School of Engineering) and Prof. Shigeo Kagami (General Manager of theOffice of Innovation and Entrepreneurship, Division of University
Corporate Relations) also exchanged views on the possibility ofcollaborative research between industry and academia with researchersand managers of Evonik.
At the research colloquium, which was given the title of “Evonik Lecture,”
Prof. Aida presented his latest research results in the area of stimuliresponsive materials. And Prof. Kagami, responsible for innovation andentrepreneurship in the business relations, provided an overview of theinstitution and its work in the area of innovation. The two professors areactive in their various fields, and were the focus of a great deal ofattention; with very lively question and answer sessions taking place,making for a thriving academic conference.
“Trustful partnerships with leading universities like the University ofTokyo are important for Evonik´s innovativeness and creativity, not only
regarding joint research collaborations, but also for employer branding
and recruiting reasons. To facilitate this, scientific exchange withuniversity professors as well as joint workshops with researchers fromEvonik are one essential activity”, says Prof. Dr. Georg Oenbrink（Headof Innovation Networks Communications）.

Page 1 of 3

Evonik Japan Co., Ltd.
Shinjuku Monolith 12F
2-3-1, Nishi-Shinjuku,Shinjuku-ku
Tokyo 163-0938
www.evonik.jp

Prof. Takuzo Aida

Prof. Shigeo Kagami

About the Global Proprius21 strategic partnership
Global Proprius21 is a five-year, long-term initiative between Evonik and The University ofTokyo, which began in 2014. The agreement seeks to facilitate collaboration in joint
research on leading-edge materials technology development and in the education of nextgeneration researchers able to achieve remarkable results in global research anddevelopment activities. Evonik and The University of Tokyo are facilitating the creation of
global social value in collaborative industry-academic research as well as fostering talent inresearch and development.
[Brief career histories of the professors]
Prof. Dr. Takuzo Aida
(Department of Chemistry and Biotechnology, School of Engineering, The University ofTokyo)
Born 1956. Doctor of Engineering. After graduating from Yokohama National University in
1979, he transferred to the School of Engineering at The University of Tokyo, andcompleted his doctorate program there in 1984. After working as a research assistant andthen later as an associate professor, in 1996 he became a full professor, and has remainedat the School of Engineering ever since. Between 2000 and 2005 he was ERATO(Exploratory Research for Advanced Technology) project leader, and from 2009 took on theadditional role of Group Director at RIKEN (the Institute of Physical and Chemical Research).
He was awarded a CSJ (Chemical Society of Japan) Award in 2009; the Fujihara Award in2010; and has also received numerous other awards, including the Humboldt Prize and theJapanese Medal of Honor with Purple Ribbon.
Prof. Kohei Tsumoto(Department of Bioengineering, School of Engineering, The University of Tokyo)
Graduated from the Department of Industrial Chemistry, Faculty of Engineering, The
University of Tokyo in March 1993, completing the Master’s program in industrial
chemistry at the School of Engineering. After withdrawing prior to completion of thedoctorate program in Chemistry and Biotechnology in July 1995, he obtained his doctorate
in Engineering from The University of Tokyo in April 1997. He began working at theGraduate School of Engineering at Tohoku University as a research associate from AugustPage 2 of 3

1995; as a lecturer from August 2001; and then as a full professor from October 2002. He
became an associate professor at the Graduate School of Frontier Sciences at The Universityof Tokyo in 2005, and full professor at the university’s Institute of Medical Science in 2010,
before arriving at his current post (a joint position also working for both the Institute ofMedical Science and the Drug Discovery Initiative), which he has held since 2013. He hasreceived numerous awards, including the Japanese Biochemical Society Encouragement
Award in 2002 and the JSPS (Japan Society for the Promotion of Science) Prize in 2012.
Prof. Dr. Shigeo Kagami(General Manager, Office of Innovation and Entrepreneurship, Division of University
Corporate Relations)
Graduated from the Faculty of Commerce and Management at Hitotsubashi University in
1982, before obtaining his MBA from IMEDE (now IMD) in Switzerland, and later his PhD inBusiness Administration from Case Western Reserve University in the United States. After
working at the Boston Consulting Group, in 1986 he participated as a founding partner inthe establishment of the strategic consulting company Corporate Directions, Inc. (CDI). Helater worked as a key executive officer and as a senior vice-president and office director at
CDI in the US. After obtaining his degree, he joined Heidrick & Struggles—one of theworld’s top executive search firms—as a partner. He became a faculty member of theGraduate School of Pharmaceutical Sciences at The University of Tokyo in September 2002.
In May 2004 he became a professor and General Manager of the Office of Innovation andEntrepreneurship in the Division of University Corporate Relations (DUCR). He wasappointed to his current post in April 2013. As from January 2016, he is now also a directorand vice president at the Japan Academic Society for Ventures and Entrepreneurs. He waspresented with the Society’s first S. Matsuda Award in 2015.

Company information
Evonik, the creative industrial group from Germany, is one of the world leaders inspecialty chemicals. Profitable growth and a sustained increase in the value ofthe company form the heart of Evonik’s corporate strategy. Its activities focus on
the key megatrends health, nutrition, resource efficiency and globalization.
Evonik benefits specifically from its innovative prowess and integrated
technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2014 more than
33,000 employees generated sales of around €12.9 billion and an operating
profit(adjusted EBITDA) of about €1.9 billion.

Disclaimer
In so far as forecasts or expectations are expressed in this press release or where
our statements concern the future, these forecasts, expectations or statements
may involve known or unknown risks and uncertainties. Actual results ordevelopments may vary, depending on changes in the operating environment.
Neither Evonik Industries AG nor its group companies assume an obligation to
update the forecasts, expectations or statements contained in this release.

Page 3 of 3